drugset / Trial / NCT02828228

Vitamin D Supplementation in Vitamin D Deficient Obese Children During Weight-loss Program

NCT02828228

RandomizedParallel-groupQuadruple-blindTreatment

Summary

1. Analyze the influence of vitamin D supplementation in obese children during weight-loss program on BMI, body composition and bone mineral density. 2. Analyze the influence of vitamin D supplementation on the risk profile of obesity-related complications, namely impaired tolerance of glucose, insulin resistance, dyslipidemia and arterial hypertension, in obese children participating in weight-loss program. 3. Analyze the prevalence of vitamin D deficiency among obese children. 4. Analyze the risk factors of vitamin D deficiency in obese children (age, gender, pubertal status).

Timeline

Start
2016-02
Primary completion
2018-02
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 1200 iu

Indications